Report error Found 237 Enz. Inhib. hit(s) with all data for entry = 13517
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 2 and E3 ubiquitin-protein ligase XIAP(Human)
Interline Therapeutics
US Patent
Interline Therapeutics
US Patent
Affinity DataIC50: 55nMAssay Description:Table A: For the assay, a working solution of 1 nM GST-RIPK2, 25 nM His-XIAP (BIR2)-avi, 6 nM Anti-His-XL665 nM (Revvity Catalogue No. 61HISXLB), and...More data for this Ligand-Target Pair

















































